UK Markets closed
NIKKEI 225
26,107.65 -315.82 (-1.20%) HANG SENG
21,586.66 -266.41 (-1.22%) CRUDE OIL
98.04 -1.46 (-1.47%) GOLD FUTURES
1,735.20 -28.70 (-1.63%) DOW
30,912.79 -55.03 (-0.18%) BTC-GBP
16,965.96 +392.17 (+2.37%)
Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:03PM EDT. Market open.
| Previous close | 596.56 |
| Open | 594.79 |
| Bid | 591.72 x 1000 |
| Ask | 592.29 x 800 |
| Day's range | 590.00 - 601.88 |
| 52-week range | 538.01 - 747.42 |
| Volume | |
| Avg. volume | 697,118 |
| Market cap | 63.644B |
| Beta (5Y monthly) | 0.21 |
| PE ratio (TTM) | 9.46 |
| EPS (TTM) | 62.53 |
| Earnings date | 03 Feb 2022 - 07 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 702.05 |
- Zacks
Regeneron (REGN) Dips More Than Broader Markets: What You Should Know
Regeneron (REGN) closed at $591.13 in the latest trading session, marking a -1.09% move from the prior day.
- Zacks
Regeneron (REGN) Eylea sBLA for Extended Regimen Accepted
FDA accepts Regeneron's (REGN) application seeking label expansion for Eylea for an extended period in patients with diabetic retinopathy.
- Motley Fool
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
Mega-blockbuster Dupixent was just given the FDA's green light to treat patients with a chronic, progressive inflammatory disease.
© 2022 Yahoo. All rights reserved.
